Posted in | News | Energy

H.E.L Group signs distribution agreement with ThalesNano Energy for H-Genie bench-top high-pressure hydrogen generator

H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced that it has signed a worldwide non-exclusive distribution agreement with ThalesNano Energy™, a developer of bench-top chemistry-focused gas generators. Covering the H-Genie® bench-top hydrogen generator and associated consumables, the agreement will provide H.E.L customers easy access to a safe, cost-effective, and space-saving alternative to traditional hydrogen cylinder installation or fixed-line supply.

The H-Genie provides a bench-top solution to high-pressure lab hydrogen supply avoiding the current cost, safety, and engineering challenges associated with laboratory set-up and maintenance of an ongoing fixed-line supply. Generating hydrogen from water up to 100 bar (1450 psi) and 1 NL/min, H-Genie removes the need for hydrogen cylinders, hydrogen lines, or compressors, combined with smart software that monitors hydrogen consumption and allows all reaction data to be easily exported.

Aimed at chemists and chemical engineers involved in catalysis studies, where high-pressure hydrogenation processes are often a key focus, the H-Genie complements H.E.L’s existing portfolio of products aimed at understanding catalytic processes. It is estimated that 85% of products manufactured involve catalysis somewhere in their production chain whether that be petrochemicals (or bio-equivalents), pharmaceuticals, new materials, transport, and environment, or essential research & development.

Understanding and addressing our customers’ lab-based challenges is central to our mission to help unleash the full potential of the scientific community. We are delighted to team up with ThalesNano Energy to expand our portfolio of tools and services for catalysis studies and provide a quick, easy solution to hydrogen supply in the lab particularly for our customers working with high-pressure applications." 

Louise Madden, Chief Executive Officer of H.E.L Group

Richard Jones, Chief Executive Officer at ThalesNano Energy said: “From our side, working with H.E.L. was a ‘no brainer’. In addition to their excellent reputation in the catalysis field, there is a large degree of synergy between our product lines. We are excited to work with H.E.L to distribute our award-winning H-Genie hydrogen generator and to make high-pressure hydrogen work accessible to every lab without the need for major reconfiguration or construction work. We look forward to building a strong working relationship with H.E.L through this strategic partnership.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    H.E.L Group. (2023, April 04). H.E.L Group signs distribution agreement with ThalesNano Energy for H-Genie bench-top high-pressure hydrogen generator. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=56007.

  • MLA

    H.E.L Group. "H.E.L Group signs distribution agreement with ThalesNano Energy for H-Genie bench-top high-pressure hydrogen generator". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=56007>.

  • Chicago

    H.E.L Group. "H.E.L Group signs distribution agreement with ThalesNano Energy for H-Genie bench-top high-pressure hydrogen generator". AZoM. https://www.azom.com/news.aspx?newsID=56007. (accessed November 21, 2024).

  • Harvard

    H.E.L Group. 2023. H.E.L Group signs distribution agreement with ThalesNano Energy for H-Genie bench-top high-pressure hydrogen generator. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=56007.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.